Biopharma company dedicated to developing new therapies for patients with respiratory diseases – with our lead candidate in development for people with #IPF
Patient voices are critical in raising awareness of #PFcough & helping prevent misdiagnosis, which happens to ~71% of patients. As we kickoff #PFMonth we are honored to unveil this video chronicling Charlene Marshall's #PF journey. See the full video here: https://t.co/o2GUkixkXw
Our CEO, @wgerhart, recently spoke with @mdaghbio about the impact the #COVID19 pandemic has had on those with #PF & the ostracization they’ve experienced because of the chronic cough associated with this disease. Read the article in @GlobalGenes here: https://t.co/2HEpB6vYoi
Hear from @IPFWarrior Bill Vick, speak to our CEO @Bill_Gerhart about #PFcough and our #SCENIC trial that is evaluating the potential of #RVT1601 to treat #IPFcough as well as the underlying disease: https://t.co/bRaC4F4x9F
It is important to talk to your doctor about your #PFcough as soon as you become concerned or symptoms of excessive coughing occur. The best support from a doctor will come from you being an empowered patient and working with them to identify a treatment option.
Amid a global #pandemic that is hypersensitized to coughing, #PF patients with persistent cough are seen as a potential threat. How can we begin to destigmatize coughing and raise awareness for PF patients in the future? Read my latest post for @respivant. https://t.co/tGAGpMcb2t
The ostracization of cough for those with #PF was significant before #COVID19, but is now significantly worse due to the pandemic, which can lead to increased anxiety, isolation and depression. It's time to stop the stigmatization of #PFcough. Read more in @pulmonaryfibros:
In the time of #COVID19, people are ostracizing those who cough in public, which has created more stress & anxiety for patients who have #PFcough. Charlene Marshall, a #PF patient, shares a few tips in @pulmonaryfibros to help w/ anxiety amid the pandemic: https://t.co/dVWQCP5AC3
Our CEO, @wgerhart, recently spoke with @dslevine for his #RARECast podcast on @GlobalGenes about #PFcough and our SCENIC study that is evaluating the potential of #RVT1601 to significantly reduce cough & improve quality of life for patients. Listen here:
Bill Gerhart, CEO of @Respivant Sciences, discusses IPF, what life with the dry persistent cough the condition can cause can be like, and the company’s experimental therapy to treat the condition. @GlobalGenes#RARECast
https://t.co/ODYzGjhZ4f
Dry cough is one of the most common, well-publicized early symptoms of #COVID19. Our CEO @wgerhart shares his thoughts on the stigma behind the cough associated with #PF that has been exacerbated by the #COVID pandemic. Read more here: https://t.co/jCil0kjEGP #PFcough
The PF Perspectives Project is accepting submissions until June 30 from patients with #PFCough. Your perspective will help healthcare innovators understand pressing challenges for #PF & develop the solutions needed to solve those challenges. https://t.co/K2KSrgZNt5
Our #SCENIC trial is evaluating the potential of #RVT1601 to treat IPF cough as well as the underlying disease; if successful RVT1601 could be the first therapy approved to significantly improve quality of life for pulmonary fibrosis patients. Learn more: https://t.co/8IP1S4ghtL
#IPF can lead to anxiety, depression and isolation, and many patients shy away from discussing the burden of their #IPFCough. Facilitating conversations around IPF can help others better understand and de-stigmatize this condition. Let’s start the discussion today.
#Pulmonaryfibrosis innovators want to hear from patients with #PFCough. Your perspective can shed light on key problems and opportunity areas for #PF. Share your story with The PF Perspectives Project today:
Don't forget to submit your story to the PF Perspectives Project! Selected participants will win a cash prize and an opportunity to work directly with innovators. Every story submitted counts as a $10 donation to the PFF. Get started at https://t.co/fG6MyP6vXL
#IPF is a rare disease which means it’s important to get connected with a #PF specialist to get the best care for your #IPF. Hear more from Taleena Koch, founder of @BreatheWithPF about how to get connected to a #PF specialist near you:
Taleena Koch, founder of @BreatheWithPF explains why you need a specialist PF pulmonologist to get the best IPF care. This is our latest expert video. Follow our #IPFRaremark series over the next 7 weeks
Did you seek a second opinion from a PF specialist? https://t.co/6SOpruu0Ca
There are currently only 2 approved drugs that have demonstrated the potential to slow the progression of IPF, but neither reduces cough or improves quality of life.
We’re evaluating the potential of #RVT1601 to significantly reduce cough & improve quality of life for patients.
Watch our video as Teresa Barnes talks about some things that almost anybody can do to raise awareness of #IdiopathicPulmonaryFibrosis
Follow our expert #IPF video series that we'll be sharing over the next 7 weeks - #IPFRaremark
https://t.co/50wP9ACbEC
There are multiple triggers that can cause patients with #IPF to have an uncontrollable coughing episode, including perfumes, spices, and temperature changes.
Potential embarrassment associated with their cough leads many patients with this disease to self-isolate. #IPFStigma